You just clicked a link to go to another website. If you continue, you will leave this site and go to a site run by someone else.
Medtronic does not review or control the content on the other website, and we are not responsible for any business dealings or transactions you have there. Your use of the other site is subject to the terms of use and privacy statement on that site.
It is possible that some of the products on the other site are not approved in the United Kingdom.
Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
The content of this website is exclusively reserved for Healthcare Professionals in countries with applicable health authority product registrations, except those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011, article 34.
Click “OK” to confirm you are a Healthcare Professional.
InterStim™ systems have been implanted in over 325,000 patients*, and evaluated in more than 1000 published clinical articles, including long-term (5-year) data for urinary frequency, urinary incontinence, retention, and faecal incontinence.(1-3)
LEARN ABOUT THE THERAPYReengineered lead designed with you and the patient in mind. Understand the two testing options available so more patients can say yes to the test.
LEARN ABOUT EVALUATIONSUse these convenient online courses to build your knowledge of InterStim™ Therapy.
SEE COURSESFollow Medtronic Pelvic Health on Twitter for the latest updates on our products and therapies.
FOLLOW US ON TWITTERUnderstand the MRI guidelines for patients with an InterStimTM system.
SEE THE GUIDELINESSiegel, S., Noblett, K.,Mangel J, et al. " Five Year Follow-up Results of a Prospective, Multicenter Study in Overactive Bladder Subjects Treated with Sacral Neuromodulation." J Urol.2018;199(1), 229 – 236.
Hull T, Giese C, Wexner SD, et al. Long-term durability of sacral nerve stimulation therapy for chronic fecal incontinence. Dis Colon Rectum. 2013;56(2):234-245.
van Kerrebroeck PE, van Voskuilen AC, Heesakkers JP et al. Results of sacral neuromodulation therapy for urinary voiding dysfunction: outcomes of a prospective, worldwide clinical study. J Urol. 2007 Nov;178(5):2029-34.
Under certain conditions; see approved labeling for details. Patients with InterStim™ SureScan™ MRI leads only.
See the device manual for detailed information regarding the instructions for use, indications, contraindications, warnings, precautions, and potential adverse events. If using an MRI SureScan® device, see the MRI SureScan® technical manual before performing an MRI. For further information, contact your local Medtronic representative and/or consult the Medtronic website at medtronic.eu website
For applicable products, consult instructions for use on www.medtronic.com/manuals.
Manuals can be viewed using a current version of any major internet browser. For best results, use Adobe Acrobat® Reader with the browser.